Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Passweg

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|January 8, 2013
Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMTA Rovó, M Aljurf, S Chiodi, et al.
Bone Marrow Transplantation|March 14, 2017
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey reportJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remissionH Oh, R P Gale, M J Zhang, et al.
Bone Marrow Transplantation|February 21, 2006
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemiaJ R Passweg, W S Pérez, M Eapen, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
The New England Journal of Medicine|July 1, 1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryG Socié, J V Stone, J R Wingard, et al.
Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[25 years allogenic bone marrow transplantation in Basel: 1973-1998]J R Passweg, A Gratwohl, A Tichelli, et al.
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|January 8, 2013
Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMTA Rovó, M Aljurf, S Chiodi, et al.
Bone Marrow Transplantation|March 14, 2017
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey reportJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remissionH Oh, R P Gale, M J Zhang, et al.
Bone Marrow Transplantation|February 21, 2006
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemiaJ R Passweg, W S Pérez, M Eapen, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
The New England Journal of Medicine|July 1, 1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryG Socié, J V Stone, J R Wingard, et al.
Bone Marrow Transplantation|November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[25 years allogenic bone marrow transplantation in Basel: 1973-1998]J R Passweg, A Gratwohl, A Tichelli, et al.
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Pageof 8